Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-26 @ 10:57 AM
Ignite Modification Date: 2025-12-26 @ 10:57 AM
NCT ID: NCT04884308
Description: None
Frequency Threshold: 0
Time Frame: 6 months
Study: NCT04884308
Study Brief: Bacille Calmette-Guerin (BCG) Vaccine for Immune Protection Against Infections
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Cystic Fibrosis Participants with Cystic Fibrosis. BCG TICE Vaccine: Intradermal vaccination with BCG TICE 0 None 0 14 12 14 View
Non Cystic Fibrosis Bronchiectasis Participants with Non Cystic Fibrosis Bronchiectasis. BCG TICE Vaccine: Intradermal vaccination with BCG TICE 0 None 0 2 1 2 View
Healthy Volunteer Participants with no condition (healthy volunteers). BCG TICE Vaccine: Intradermal vaccination with BCG TICE 0 None 0 14 12 14 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Injection site pain SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Swelling SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
pustule SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View